Trial site
Ottawa Hospital Cancer Centre
- 9running trials
- 3closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Ovarian cancer4 trials
- Kidney cancer3 trials
- Lung cancer3 trials
- Colorectal cancer2 trials
- Endometrial cancer2 trials
- Gastric and oesophageal cancer2 trials
- Prostate cancer2 trials
- Triple-negative breast cancer2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Head and neck cancer1 trial
- Metastatic breast cancer1 trial
- and 4 more
- Phase
- Phase 34 trials
- Phase 23 trials
- Phase 12 trials
- Phase 1/22 trials
- Status
- Active, not recruiting8 trials
- Completed2 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Eisai Inc.2 trials
- Seagen, a wholly owned subsidiary of Pfizer2 trials
- 23andMe, Inc.1 trial
- ALX Oncology Inc.1 trial
- Esperas Pharma Inc.1 trial
- and 5 more
Running trials
Active, not recruiting
Active, not recruiting
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies
Active, not recruiting
Active, not recruiting
Recruiting
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
Active, not recruiting
Active, not recruiting
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026